Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Black Hawk Acquisition Corporation (BKHA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Black Hawk Acquisition Corporation (BKHA), most recent 12 months reported: net income $1.3M. Latest balance sheet on file: liquid cash $39.52K, total debt $595.37K, net cash -$555.85K. From SEC filings. Others in Biological Products, (No Diagnostic Substances): BIOATLA, INC. · BioCardia, Inc. · BRAINSTORM CELL THERAPEUTICS INC. · BLACK DIAMOND THERAPEUTICS, INC. · CABALETTA BIO, INC. · CANDEL THERAPEUTICS, INC. · CERO THERAPEUTICS HOLDINGS, INC. · CULLINAN THERAPEUTICS, INC.

Stock screener

Watchlist